People often look back at the early 20th century as the start of a focused interest in amino acids like histidine. During that period, researchers began to unlock the mysteries of basic building blocks of proteins, laying groundwork for what would eventually become routine applications in food, pharma, and research labs. Histidine’s identification as one of the essential amino acids contributed to walking protein science out of obscurity. Over the decades, newer extraction, refinement, and synthesis technologies have made histidine and its hydrochloride salt not only more accessible but also purer and more consistent for pharmaceutical use. Discussions between academic chemists and industry specialists in the late 1960s set the stage for the strict guidelines that are now reflected in the current BP, EP, and USP standards.
Histidine shows up as a white crystalline powder or can form colorless crystals. Its hydrochloride salt, used in pharma-grade products, carries the same core structure with one more layer of control for purity and stability. Medical suppliers and chemical companies often source histidine hydrochloride with a 99% assay, a level that reflects tough scrutiny and repeat testing. In my own experience in research, only a few compounds are monitored as carefully in the chain from production to end-use. Whenever a batch falls even a hair below those benchmarks, producers get questions fast from their clients, since people depend so strongly on consistency. For medical injection, infusion solutions, and biotechnological synthesis, even a faint trace of contamination or a slight shift in pH can cause users to reject an entire load.
Histidine holds a molecular formula of C6H9N3O2, while its hydrochloride form includes the extra Cl—showing up as C6H9N3O2·HCl. A key reason chemists value histidine lies in its imidazole ring, a structure that isn’t only reactive but also keeps the amino acid stable at room temperature. As a powder, histidine hydrochloride dissolves well in water—nearly 50 g/l at 20°C. It doesn’t carry a strong odor, and tastes slightly bitter, facts which matter greatly in pharmaceutical compounding. Melting points reported hover around 288°C (decomposition), pointing to the kind of stability that allows it to survive the heat swings of shipping and storage. Its isoelectric point is close to 7.47, which gives it special utility in buffer creation and pH regulation.
Any pharma-grade amino acid comes with its own dense sheet of technical specs tying each batch directly to BP, EP, and USP pharmacopeiae. Documentation walks through everything from heavy-metal content, sulphate ash, and optical rotation, to microbial burden. Specs for histidine hydrochloride regularly demand a minimum assay of 98.5%, loss on drying less than 0.5%, and specific limits on endotoxins for injectable products. Vials, drums, or plastic-lined fiber containers will always come marked with batch codes, expiration dates, and compliance badges. Labels also mention storage instructions—usually cool, tightly closed containers away from light—because shelf stability influences both shelf-life and patient safety. In practice, even small clinics pay attention to these details before accepting a shipment in.
Histidine once came mostly from hydrolyzed proteins or yeast extracts, a method that brought variable outcomes. Today, large-scale production mainly turns to fermentation using particular strains of microorganisms that can churn out histidine in bulk. Following fermentation, chemical conversion steps yield the hydrochloride salt through acidification and precipitation. Quality checks strip out any potential byproducts. The focus on fermentation and refinement comes from growing need for both vegan and kosher/halal certified inputs, especially after regulatory agencies started demanding transparency at all stages. Lab synthesis sometimes fills urgent gaps, but it is rare. My time spent consulting for a mid-sized chemical provider showed me that buyers push back against anything not backed by full traceability, which has forced firms to track and document every ingredient and step.
The story of histidine’s use is really about its chemistry. The imidazole ring endows the compound with the ability to donate and accept protons—a rare trait among amino acids. This single feature sparks applications in enzymes, buffer solutions, and drug delivery vehicles. Chemists modify histidine to create methylated or acetylated derivatives, often adding flexibility for use in peptide synthesis or pharmaceutical research. Its reactive carboxyl and amine groups participate in condensation reactions, cross-linking, or conjugation with drug molecules. These changes sometimes create better absorption, solubility, or stability, giving pharmaceutical researchers plenty of ground to experiment. Technical teams with biotech companies often try small tweaks to the structure in pilot runs to see how it handles stress before scaling up.
A scroll through a chemical catalog might show histidine called by names such as L-Histidine, (S)-α-Amino-1H-imidazole-4-propionic acid, or 2-Amino-3-(1H-imidazol-4-yl)propanoic acid. For the hydrochloride version, expect to see “L-Histidine Monohydrochloride Monohydrate,” “Histidine-(HCl),” or simply “Pharma Grade L-Histidine HCl.” Trade names sometimes tack on “USP,” “EP,” or “BP” to make clear their compliance with different international standards. In the real-world context of ordering or research, a buyer calling up a supplier by a trade name needs to watch the fine print; purity levels and forms of hydration can change product handling and shelf-life.
Most of the time, histidine and its hydrochloride salt rank as low-risk for professional handlers, but the industry still keeps to clear protocols. Material Safety Data Sheets spell out low acute toxicity, yet warn about inhalation or eye contact from powders. Glove, goggle, and dust mask use comes standard in most production areas. For injectable or infusion-grade material, cleanroom conditions and regular batch testing prevent microbial or cross-contaminant risks. In my consulting work, the strongest reactions I’ve seen from regulators have come after even trace-endotoxin positives, raising red flags about process control and infrastructure. Focusing on operator training, audit trails for every shipment, and full traceability of each processing batch matters as much for public trust as it does for patient safety.
Histidine hydrochloride turns up across an impressively broad stretch of medicine and biotechnology. In hospitals, patients with metabolic disorders or those fed via parenteral nutrition depend on histidine-enriched IV solutions. Histidine’s buffering power makes it staple in hemofiltration and dialysis fluids. Vaccine production uses it as a stabilizer, a function that extends to some monoclonal antibody drugs brought to market in the last decade. Biopharmaceutical manufacturers rely on it for cell culture media, where exact amino acid concentrations can sway the yield or purity of biologics. Technical research teams sometimes use it to study protein structure and enzyme kinetics, taking advantage of that unique imidazole chemistry. Over time, clinical trials in rare pediatric disorders, such as histidinemia or enzyme deficiencies, have increased—often pulling in histidine supplements or solutions as part of treatment protocols.
Researchers continue to try and uncover new uses for histidine and its derivatives. For a long time, science viewed amino acids somewhat simply, but advances in protein engineering, drug delivery, and regenerative medicine have changed the conversation. Pharmaceutical companies fund trials into histidine’s antioxidant properties, seeking insight into possible brain protection after injury, or in chronic inflammatory disease. Vaccine researchers keep a close eye on stabilization chemistry, with histidine’s unique pKa value making it a key focus. In academic partnerships, exploration of histidine’s interactions with metals fuels innovation in diagnostics, targeted drug delivery, and imaging. During my years in a university research lab, grant calls often looked for new ways to harness histidine’s chelating powers, both for cleaning up environmental pollutants and for biotechnological assays.
Histidine, like many amino acids, breaks down into harmless compounds inside the body, but only up to a point. Studies point to low oral and intravenous toxicity, supporting its approval as a nutritional supplement and for use in clinical infusions. Still, animal studies show that mega-doses may throw off mineral balances, particularly zinc and copper levels, so doctors monitor patients with certain metabolic disorders. Clinical case reports rarely document adverse reactions, but overdoses in patients with impaired kidney function have flagged caution about possible buildup and secondary complications. Toxicologists run routine assays to watch for side products or contaminants in pharma-grade histidine, since small children, the elderly, and immunocompromised patients make up a large part of the exposure group.
Interest in histidine and its pharma-grade hydrochloride variant won’t slow down anytime soon. As personalized medicine, injectable biologics, and advanced gene therapies gain ground, the demand for amino acids free of animal-sourced contaminants and with ultra-low levels of heavy metals puts pressure on suppliers to refine their practices. Questions of sustainable sourcing have taken center stage along with traceability. Growth in synthetic biology hints at possible tailored variants of histidine with tuned reactivity or binding profiles, opening doors for new cancer or rare disease treatments. Efforts by international agencies to harmonize pharmacopoeial requirements could cut bureaucracy for global shipments, moving science closer to real-time regulation changes. Companies and researchers remain eager to fill in gaps—in production, in applications, or in developing purer, safer compounds—driven by both commercial demand and the needs of ever-broader populations.
Walk into any research facility or production plant for pharmaceuticals, and at some point, histidine makes an appearance. This amino acid doesn’t just build proteins. Doctors and manufacturers both count on it in very specific ways. For example, parenteral nutrition formulas—those essential intravenous solutions used in hospitals for patients unable to eat—include histidine because the human body can’t always make enough during illness or injury. Its role in producing hemoglobin and maintaining pH in the bloodstream is well documented by medical literature, and clinicians rely on these basic properties to care for the critically ill.
Histidine hydrochloride, the stable salt form, brings even more value in medicine. Drug manufacturers include it as an excipient, helping stabilize active ingredients in injectables and lyophilized powders. The strict quality standards—BP, EP, and USP—aren’t there for marketing. Pharmaceutical grade guarantees consistency batch after batch, which matters when patients’ safety depends on it. Lyophilization is notoriously harsh on some drug molecules, and histidine salts add a buffer that shields those actives, so patients get the dose they need—nothing more, nothing less.
Malnutrition doesn’t just occur in less developed regions. Any hospital sees patients who can’t take regular food due to digestive illnesses or surgery. In these cases, pharmaceutical-grade histidine or its hydrochloride form isn’t just an ingredient; it’s a critical component of life-sustaining formulas. Enteral and parenteral feeds would be far less effective—or unsafe—without accurate amino acid profiles, and histidine’s presence helps avoid metabolic issues related to deficiency. Regulatory agencies like the FDA and EMA have clear guidelines requiring the use of pharmaceutical-grade ingredients to protect patients from impurities or toxicity.
Many vaccines in the last decade have turned to specific amino acids for stability. Here, histidine hydrochloride stands out. Big vaccine manufacturers, as well as small biotech startups, report that it improves the shelf life of sensitive molecules, especially proteins and peptides used in modern immunizations. In my own experience working with formulation scientists, adjusting histidine concentrations in a buffer brought measurable improvements: fewer aggregation issues in protein drugs, less loss of potency on storage, and improved reproducibility from vial to vial. The COVID-19 pandemic put enormous pressure on supply chains, reminding everyone that keeping drugs effective for months or years isn’t just science—it’s an ethical responsibility.
Reliance on consistent supply makes traceability and documentation critical, particularly when exporting products worldwide. Some regions struggle with supply interruptions caused by trade disruptions or natural disasters, impacting patient care. Pharmaceutical companies could invest in redundant sourcing and conduct additional batch testing to ensure continued safety and effectiveness. Increased transparency from ingredient suppliers—as well as faster data sharing about recalls or contamination—would help pharmaceutical manufacturers respond more quickly, minimizing risk to patients.
I’ve seen firsthand that seemingly small details—like the precise content of an amino acid—can impact the lives of vulnerable patients. In oncology, neonatal care, or infectious disease settings, doctors and pharmacists depend on that reliability. For those making, prescribing, or receiving modern medicines, quality histidine and histidine hydrochloride aren’t just ingredients on a label—they help set the standard of care.
Companies often spotlight their products and throw impressive numbers onto spec sheets, but for the folks using these items, especially in scientific or industrial settings, those tiny details matter. Purity isn't just some checkbox for compliance—it's the difference between a successful experiment and wasted time or materials. If you're in pharmaceuticals, any fault in purity can ripple down to the very pill in a medicine bottle.
I’ve watched plenty of buyers get burned by missing information on datasheets. A number like “99% purity” alone can give a false sense of security. What about the remaining 1%? Impurities, even in trace quantities, can create huge headaches. Think batch contamination, machine fouling, faulty product runs, or—worst of all—health risks. No reputable chemical lab just takes “99%” at face value without seeing a breakdown of what else is in there. Community trust grows stronger when a supplier shows not just results but how they ran their tests and what standards they followed. A real certificate of analysis should back up every figure, listing heavy metals, moisture, ash, and any residual solvents.
Back in graduate school, I worked with reagents where a few extra parts per million of contamination tanked entire lines of research. You’d spend weeks troubleshooting only to discover a supplier quietly changed their process. The cost isn’t just financial; it’s a blow to productivity, reputation, and even safety.
In my recent years consulting for manufacturing plants, it became even clearer—machines start wearing out faster when the material isn’t as pure as promised. That leads to shutdowns, lost revenue, and angry calls from clients. Downstream users—be it in food processing, electronics, or even cosmetics—don’t want surprises either. Purity transparency can save headaches for everyone.
A 2022 FDA report flagged nearly 40% of pharmaceutical recalls as linked to contamination or out-of-spec substances. And in the specialty chemicals sector, trade bodies like ASTM and ISO lay out clear rules for measurement and paperwork because even a single impurity can render a process useless. Skipping these due diligence steps exposes both suppliers and customers to risk.
For buyers working in regulated markets, certificates that just say “99+%” without method validation or impurity profiles might not even meet compliance rules. Testing protocols should be recent, recognized (like ICP-MS or HPLC), and the results should tell more than a single number. Transparency matters to everyone from procurement staff to quality control scientists.
Getting full transparency means you can trace a problem to its root and not just patch over symptoms. I always suggest suppliers keep open lines of communication—if something changes in their raw materials or processes, tell clients early. Customers who see that effort don’t bolt at the first hiccup; they usually stick around longer, because openness reassures them.
For those making buying decisions, don’t settle for vague specs. Press for full certificates of analysis, clarification of test methods, and any available data on contaminants. And for those selling, investing in rigorous quality checks isn’t wasted money—it’s the foundation for customer loyalty and brand reputation.
Patients who rely on injectable drugs trust each dose with their lives. If a product claims it's suitable for injectable or pharmaceutical use, no one can afford to take that label at face value.
I’ve spent years reading through pharmaceutical specifications, sitting across from regulators, and talking with doctors who see every side effect in real time. These professionals depend on products that meet tough standards, not products that look fine or pass some basic tests. Safety isn’t about what you don’t see—like visible dirt or discolored powder. It gets decided by what’s measured in parts per million or billion. Any contaminant makes its way into a patient’s bloodstream, and small mistakes can have lifelong consequences.
Every injectable drug component, additive, or solution lives under the microscope of quality control. This isn’t just about ticking boxes on a checklist. For a product used in injectable preparations, it needs data: purity, pyrogen content, sterility, residual solvents, heavy metals, all carefully quantified, batch after batch. If anyone glosses over this, it’s not just poor practice—it’s playing dice with people’s health.
It takes global standards to protect patients. Pharmacopeia monographs—like USP, EP, JP—remain essential references. Each batch must prove itself through these rigorous processes. Take sterile filtration; it isn’t enough to run it though a filter. Operators test for bacterial endotoxins and validate sterility, following environments controlled for airborne organisms and particulate matter. Change a single step, and the risk profile jumps.
Manufacturers can’t expect trust without real transparency. Anyone wanting to bring a pharmaceutical product to market—especially for injection—needs to show traceability for every ingredient and step. Full documentation, clear certificates of analysis, robust batch records. Anything less puts everyone downstream in a defensive position.
I’ve worked with pharmacists who demand lot traceability and explicit source documents before accepting any component for compounding. If a vendor isn’t providing this by default, the question isn’t suitability—it’s liability.
Regulatory agencies do not exist to restrict business; they protect patients who must trust that “pharmaceutical grade” means something real. Every withdrawal, recall, or reported injury shows what goes wrong when shortcuts slip in. Singapore’s Health Sciences Authority, the US FDA, Europe’s EMA—they all put out alerts about falsified components or tainted raw materials slipping into the injectable supply chain. These aren’t rare; anyone in this industry has seen them stack up.
I remember a pharmacy hospital team forced to halt patient care because an excipient lot failed an impurity test by a fraction. But because they caught it, none of their patients got harmed. These nearly invisible lines become lifelines in a field where the margin for error equals the margin for disaster.
There’s only one way for a product to truly fit injectable or pharmaceutical use: show the credentials at every step. Full identity and purity, validated by third-party audits and inspections, plus a willingness to share results and documentation. No side door just because something’s “almost” pure, or “technically” sterile. Only relentless, open verification grants access to patient care.
Anyone asking “is this suitable for pharmaceutical and injectable use?” is, at heart, asking “can I trust this with a life?” No marketing, cost savings, or speed will ever matter more.
Most products hit store shelves in an array of sizes. Walk into any grocery, pharmacy, or supply store and that’s clear as day. Brands put effort into sizing that matches people’s real lives. In my own home, I’ve bought gigantic bags of rice for family gatherings and the smallest spices for everyday cooking, just so nothing goes stale. In the same way, industries and consumers ask suppliers for bulk containers, sample packs, and everything in between.
These decisions don’t come from nowhere. Small-scale users—caterers, DIY enthusiasts, research labs—lean toward manageable pack quantities. Five-gram packets, 100ml bottles, and small pouches keep waste down and expenses tight. Then there are those who order by the gallon, kilogram, or drum. Large factories, commercial kitchens, or warehouse clubs move through stock faster than a small shop ever could.
Shelf life describes how long a product actually stays useful. That date can change the whole story. One memory: I stocked up during a major sale on pantry goods, only to watch cans expire before I could use them. That taught me to check not just what I need, but for how long I’ll really use it. It’s the same idea for manufacturers and retailers. Too short a shelf life, and stock ends up in the trash before anyone benefits. Stretch storage too long, and you risk quality or safety.
It’s not just about putting a date on a box. Temperature swings, light exposure, humidity—these all change how long a product holds up. Pharmaceuticals can degrade without proper controls. Food spoils if it sits too long. Even industrial chemicals need careful management. Regulatory bodies like the FDA and the EPA set rules for a reason: public safety and transparency start with reliable data. Authentic companies don’t take shortcuts here, since their naming and reputation ride on trust.
For anyone buying, size and shelf life can mean the difference between savings and waste. Are you a small operation? Choose smaller packs and update orders more often. Run a growing business? Plan stock turnover in sync with sales numbers and forecast need against storage conditions. No one likes to lose money, but skimping on right-sized orders and ignoring expiration dates leads to bigger headaches down the road.
On the store side, accurate labeling stands out. People should see clear “best before” markers and honest volume listings. Having worked retail floors, I saw customers skip products with unclear dates or confusing packaging. Smart shops rotate shelves, keep cold-chain essentials at the correct temps, and train staff to spot trouble fast. Mistakes hurt consumer trust faster than almost anything else.
Longer shelf life starts with better packaging. Airtight seals, UV-blocking containers, moisture control—these upgrades go beyond simple design. Recyclable packs lighten the load for waste management, too. Digital inventory tracking, once a luxury, now fits most budgets and prevents expired stock from piling up. If products require refrigeration, real-time monitoring helps keep every batch at its best. Staff training, transparency, and technology: these improve outcomes from production line to end user.
Every time someone steps into a laboratory or a pharma facility, they carry responsibilities that stretch beyond technical know-how. Small lapses, especially with pure substances like Histidine Hydrochloride BP EP USP pharma grade, can unravel research or production. Storing this compound isn’t about following written rules for the sake of compliance; it’s about avoiding ruined batches, cross-contamination, and unnecessary risks to people and products. In my own routine running sample prep for amino acid analyses, even leaving a jar open for a minute too long led to clumped powders and wild swings in measured content.
Histidine Hydrochloride isn’t fond of water in the air. Dry, tight storage makes a difference. Once, I watched a colleague ignore this simple need, stacking opened bottles on a regular shelf. Within a week, the powder stuck together in clumps and became harder to dissolve. So, it always goes in a tightly sealed container, tucked away in a cool, dry cabinet. Pharma-grade batches go straight into desiccators or air-tight jars with silica gel packs. Simple steps stop headaches later on, and they keep the material true to its label.
Lab people like me sometimes debate if Histidine Hydrochloride wants refrigeration. Most sources settle on “ambient temperature”—not the fridge, but none of that warehouse heat either. High heat triggers breakdown and shortens shelf life. At my place, the best spot sat in the main supply room, far from sunlight, with climate control set to standard room temperature. I’ve learned it’s about stability, not perfection. Too cold, condensation creeps in whenever bottles get opened. Too warm, and yellowing starts along the inside of storage jars.
People moving between synthesis, sampling, and analysis sometimes grow casual. I’ve made that mistake, scooping powder without gloves because I thought it was “just” an amino acid. The result: not only does that risk skin irritation, but finger moisture finds its way into the powder. Disposable gloves, protective goggles, and a good lab coat are non-negotiable. No one wants unexpected side effects, especially if the powder scatters. Pouring and weighing inside a fume hood or dedicated workspace keeps everything clean. Spills seem minor until clean-up turns into a guessing game about ingredient loss or, worse, cross mistakes into other workflow benches.
Some might gloss over safety data sheets because the hazard rating looks low. But pharma grade standards don’t just pop into place—labs get their quality by respecting every stage, including disposal. Residual material shouldn’t go down a sink or regular trash. My experience tells me the cost to fix a contaminated line or respond to a chemical burn dwarfs the time spent following protocols. Collect waste powder in a labeled bin, and hand it off for approved disposal. Every bit of diligence here saves real money, real time, and sometimes, real skin.
Each small decision—tightening a cap, choosing the right shelf, putting on gloves—adds up to more than just compliance. It’s about pride in the work and respect for both colleagues and the people relying on the final product. Solutions exist in practical habits. Build a checklist with colleagues, walk new hires through your own good habits, and challenge shortcuts wherever you spot them. Decades in pharma and lab life have taught me that the best outcomes follow from simple, thoughtful action every single day.
Names | |
Preferred IUPAC name | 2-Amino-3-(1H-imidazol-4-yl)propanoic acid |
Other names |
L-Histidine Histidine Monohydrochloride Histidine HCl 2-Amino-3-(1H-imidazol-4-yl)propanoic acid hydrochloride L-Histidine Hydrochloride Histidin |
Pronunciation | /ˈhɪstɪdiːn/ /ˈhɪstɪdiːn ˌhaɪdrəˈklɔːraɪd/ |
Identifiers | |
CAS Number | 71-00-1 |
3D model (JSmol) | `3DHBIO{322}@3HIS(PH)CL` |
Beilstein Reference | 1722454 |
ChEBI | CHEBI:27577 |
ChEMBL | CHEMBL1147 |
ChemSpider | 5359 |
DrugBank | DB00117 |
ECHA InfoCard | EC 200-745-3 |
EC Number | 262-082-5 |
Gmelin Reference | 520118 |
KEGG | C00135 |
MeSH | D006631 |
PubChem CID | 6267 |
RTECS number | MF3760000 |
UNII | U6VZ63A666 |
UN number | UN3334 |
CompTox Dashboard (EPA) | DTXSID8046847 |
Properties | |
Chemical formula | C6H9N3O2·HCl |
Molar mass | 209.63 g/mol |
Appearance | White or almost white crystalline powder |
Odor | Odorless |
Density | 1.59 g/cm³ |
Solubility in water | Freely soluble in water |
log P | -3.32 |
Acidity (pKa) | 6.0 |
Basicity (pKb) | 6.04 |
Magnetic susceptibility (χ) | −1.14 × 10⁻⁶ |
Dipole moment | 13.13 D |
Thermochemistry | |
Std molar entropy (S⦵298) | 163.0 J·mol⁻¹·K⁻¹ |
Std enthalpy of formation (ΔfH⦵298) | -314.9 kJ/mol |
Std enthalpy of combustion (ΔcH⦵298) | -1585.6 kJ/mol |
Pharmacology | |
ATC code | B05XA |
Hazards | |
Main hazards | May cause respiratory and skin irritation. |
GHS labelling | GHS07, GHS08, Warning, H315, H319, H335 |
Pictograms | GHS07 |
Hazard statements | Hazard statements: Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008. |
Precautionary statements | Precautionary statements: P261, P264, P270, P271, P280, P301+P312, P304+P340, P305+P351+P338, P312 |
NFPA 704 (fire diamond) | Health: 1, Flammability: 0, Instability: 0, Special: - |
Flash point | No flash point required |
LD50 (median dose) | LD50 (median dose): Mouse oral 12 g/kg |
PEL (Permissible) | PEL: Not established |
REL (Recommended) | 30 mg/kg |
Related compounds | |
Related compounds |
Histidine hydrochloride monohydrate L-Histidine Histamine Histidine methyl ester Histidine dihydrochloride Histidinol Imidazole L-Histidine•HCl•H2O |